67-year-old male with a history of hidradenitis suppurativa (HS) came to our hospital complaining symptoms of decompensated heart failure of 2 weeks of evolution after the re-initiation of adalimumab for his HS. Other causes of heart failure were ruled out. Unfortunately, the patient died secondary to heart failure and septicemia.